Accel Partners
+12.21%
3か月リターン
$41.070
+2.337 (+5.69%)終値時点
Ethos Technologies Inc. is a United States-based life insurance company. The Company offers whole life insurance and term life insurance. Its whole life insurance provides accidental death benefit and death benefit. Its term life insurance offers monthly payment of premiums that do not increase during the term. It is provided for age 65-85 years. Its term life insurance provides coverage for a term typically 10-30 years. The Company operates in every United States and the District of Columbia.
Ethos Technologies Inc. (LIFE) is a good buy right now due to its strong financial performance, highlighted by a Q2 revenue of $190 million which is a 113.8% year-over-year increase, and a non-GAAP EPS of $0.53 that exceeded expectations by $0.25. Additionally, the company has a gross margin of 97.06% in Q2 2026, indicating robust profitability. The main risk is the recent net income loss of $172 million in Q1 2026, which could impact investor sentiment.

Ethos Technologies to Release Q3 2026 Financial Results

Ethos Signs Erin Andrews as Brand Ambassador

aTyr Pharma Presents Significant Advancements in Efzofitimod Research

Ethos Technologies Reports Strong Q2 Results, Shares Surge 24%

Ethos Technologies Reports Exceptional Q2 2026 Earnings Growth
Ethos Technologies Inc. is a United States-based life insurance company. The Company offers whole life insurance and term life insurance. Its whole life insurance provides accidental death benefit and death benefit. Its term life insurance offers monthly payment of premiums that do not increase during the term. It is provided for age 65-85 years. Its term life insurance provides coverage for a term typically 10-30 years. The Company operates in every United States and the District of Columbia. It operates in the Financials sector (BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) industry).
Ethos Technologies Inc. (LIFE) is a good buy right now due to its strong financial performance, highlighted by a Q2 revenue of $190 million which is a 113.8% year-over-year increase, and a non-GAAP EPS of $0.53 that exceeded expectations by $0.25. Additionally, the company has a gross margin of 97.06% in Q2 2026, indicating robust profitability. The main risk is the recent net income loss of $172 million in Q1 2026, which could impact investor sentiment.
投稿はまだありません
登録またはログインして議論に参加本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。